Success Metrics

Active Trials
9(69%)

Phase Distribution

Ph phase_1
4
31%
Ph not_applicable
6
46%

Phase Distribution

4

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
4(40.0%)
N/ANon-phased studies
6(60.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

9

trials recruiting

Total Trials

13

all time

Status Distribution
Active(12)
Terminated(1)

Detailed Status

Recruiting8
Not yet recruiting3
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
9
Success Rate
N/A
Most Advanced
Phase 1

Trials by Phase

Phase 14 (40.0%)
N/A6 (60.0%)

Trials by Status

recruiting862%
withdrawn18%
active_not_recruiting18%
not_yet_recruiting323%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
OTHER
Total Trials
13